Get the tools used by (smart)2 investors.

Levered FCF CAGR (7y)

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

1.00
Price
Fair Value
Upside
0.98 - 7.79
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on 's Levered FCF CAGR (7y):

INZYHLTH.USAIMDCDNAWINTOLMAVCNX6.0%7.0%8.0%9.0%10.0%

Performance Summary
  • Levered fcf cagr (7y) for Inozyme Pharma Inc is not meaningful. While computing the change, we detected that the latest value is negative, making the calculation not meaningful.

How does Inozyme's Levered FCF CAGR (7y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Inozyme Pharma Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Levered FCF CAGR (7y)

Hide this widget
fcf_levered_cagr_7y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Levered FCF CAGR (7y) in the growth category include:

View Full List

Search for metric or datapoint

Levered FCF CAGR (7y)

Seven-year compound annual growth rate in levered free cash flow.

Definition of Levered FCF CAGR (7y)

Hide this widget
Seven-year compound annual growth rate in levered free cash flow.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-26.6%3.4%33.4%79.7%103050

The chart above depicts the distribution of levered fcf cagr (7y) for companies operating in the Healthcare sector in the Developed economic region. Over 400 companies were considered in this analysis, and 390 had meaningful values. The average levered fcf cagr (7y) of companies in the sector is 10.4% with a standard deviation of 17.5%.

Inozyme Pharma Inc's Levered FCF CAGR (7y) of NM- ranks in the - percentile for the sector. The following table provides additional summary stats:

Levered FCF CAGR (7y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents406
Included Constituents390
Min-27.4%
Max77.5%
Median7.8%
Mean10.4%
Standard Deviation17.5%

You can find companies with similar levered fcf cagr (7y) using this stock screener.

All rights reserved. Terms Of Use